MML And AI Models Read More 6 minute read The Impact of AI and ML Models on Drug Discovery for Obesity TreatmentsbyQuantStrategy.io TeamMay 4, 2026 The Impact of AI and ML Models on Drug Discovery for Obesity Treatments is fundamentally reshaping the pharmaceutical…
SStrategy Backtesting Read More 6 minute read Backtesting Thematic Portfolios: GLP-1 Exposure and Market PerformancebyQuantStrategy.io TeamMay 4, 2026 Backtesting thematic portfolios: GLP-1 exposure and market performance has become a critical discipline for quantitative and fundamental investors…
TTechnical Indicators Read More 6 minute read Technical Indicators for Timing Entries in Eli Lilly and Novo NordiskbyQuantStrategy.io TeamMay 4, 2026 Investing in the pharmaceutical giants leading the metabolic health revolution requires more than just understanding the science of…
SStocks and ETFs Read More 6 minute read Medical Device Companies Under Pressure: The GLP-1 Threat to Traditional TreatmentsbyQuantStrategy.io TeamMay 4, 2026 The healthcare landscape is undergoing a seismic shift as glucagon-like peptide-1 (GLP-1) receptor agonists, originally designed for type…
SStrategy Backtesting Read More 6 minute read How to Backtest a Biotech Portfolio: GLP-1 Sector Performance AnalysisbyQuantStrategy.io TeamMay 4, 2026 Investing in the pharmaceutical sector, specifically within the rapidly evolving weight loss market, requires a blend of fundamental…
SStocks and ETFs Read More 6 minute read The Impact of Weight-Loss Drugs on Traditional Heart Failure Device ManufacturersbyQuantStrategy.io TeamMay 3, 2026 The rapid ascent of glucagon-like peptide-1 (GLP-1) receptor agonists has sent shockwaves through the medical technology sector, specifically…
SStocks and ETFs Read More 5 minute read Bariatric Surgery Stocks vs. Weight Loss Drugs: Evaluating the Competitive LandscapebyQuantStrategy.io TeamMay 3, 2026 The healthcare landscape is witnessing a seismic shift as the debate over Bariatric Surgery Stocks vs. Weight Loss…
SStocks and ETFs Read More 5 minute read High-End vs. Budget Gyms: Which Business Model Survives the GLP-1 Shift?byQuantStrategy.io TeamMay 3, 2026 As the healthcare landscape undergoes a seismic transformation, the fitness industry is grappling with a fundamental question: High-End…
SStocks and ETFs Read More 6 minute read The Healthcare Sector Transformation: How GLP-1s are Redefining Patient Care ModelsbyQuantStrategy.io TeamMay 3, 2026 The Healthcare Sector Transformation: How GLP-1s are Redefining Patient Care Models represents one of the most significant shifts…
SStrategy Backtesting Read More 5 minute read Analyzing Fitness Industry Stocks Recovery: Post-Pandemic vs. Post-GLP-1byQuantStrategy.io TeamMay 3, 2026 Analyzing Fitness Industry Stocks Recovery: Post-Pandemic vs. Post-GLP-1 requires a nuanced understanding of how market drivers have shifted…